No Data
No Data
Sharps Technology Enters Into 5-Year Sales Agreement With Strategic U.S. Medical Products Company Creating +$50M In New Revenue For EU Facility, Definitive Agreement Sells Out The 10mL SoloGard Production Capacity At Sharps' Manufacturing Site
Sharps Technology Clinches Major Syringe Supply Deal With Stericare
Express News | Sharps Technology Enters Into a Five-Year Sales Agreement With Strategic U.S. Medical Products Company Creating +$5O Million in New Revenue for EU Facility
Sharps Technology: Securities Will Be Delisted Unless Company Requests Hearing and Appeals Nasdaq's Determination by July 16
Sharps Technology: Pursuant to Nasdaq Letter July 9, Company Hasn't Regained Compliance With Listing Rule
Sharps Technology Announces Crucial Financial Update
No Data